Jan 22, 2021
In the summer of 2019, the Institute for Clinical and Economic Review (ICER) hosted a public meeting to discuss its value assessments of new treatments for Duchenne muscular dystrophy. For patient advocates and others who follow ICER, the events of that day have...
Aug 12, 2019
Their kids have a rare and fatal disease. This unelected, unaccountable industry insider just told a group of Duchenne moms: “That’s why we don’t have you vote.” Dr. Steve Pearson just might be the most powerful insider in health insurance. He’s the president of...
